Table 2.
Unadjusted and Adjusted Odds Ratio for 30-, 60-, and 90-Day All-Cause Mortality in National Lung Screening Trial (n = 379) and Surveillance, Epidemiology, and End Results National Lung Screening Trial–Eligible Cohorts (n = 3,870)
| Effect | OR | 95% CI | P Value | |
|---|---|---|---|---|
| 30-d all-cause mortality |
|
|
|
|
| Unadjusted |
Group (NLST) |
1.10 |
0.47–2.56 |
0.83 |
| Adjusted |
Group (NLST) |
1.02 |
0.43–2.40 |
0.97 |
| |
Age at diagnosis |
1.09 |
0.99–1.19 |
0.08 |
| |
Stage (1B) |
1.09 |
0.66–1.82 |
0.74 |
| |
Charlson Index (1) |
1.70 |
1.01–2.85 |
0.05 |
| |
Sex (female) |
0.59 |
0.35–1.00 |
0.05 |
| |
Smoking status (former) |
0.87 |
0.53–1.44 |
0.59 |
| 60-d all-cause mortality |
|
|
|
|
| Unadjusted |
Group (NLST) |
0.91 |
0.44–1.88 |
0.79 |
| Adjusted |
Group (NLST) |
0.84 |
0.40–1.76 |
0.65 |
| |
Age at diagnosis |
1.03 |
0.96–1.11 |
0.37 |
| |
Stage (1B) |
1.15 |
0.77–1.73 |
0.49 |
| |
Charlson Index (1) |
1.40 |
0.93–2.11 |
0.10 |
| |
Sex (female) |
0.58 |
0.38–0.87 |
0.01 |
| |
Smoking status (former) |
0.84 |
0.56–1.25 |
0.38 |
| 90-d all-cause mortality |
|
|
|
|
| Unadjusted |
Group (NLST) |
0.81 |
0.41–1.61 |
0.55 |
| Adjusted |
Group (NLST) |
0.77 |
0.39–1.54 |
0.46 |
| |
Age at diagnosis |
1.02 |
0.96–1.09 |
0.54 |
| |
Stage (1B) |
1.38 |
0.96–1.99 |
0.08 |
| |
Charlson Index (1) |
1.30 |
0.90–1.87 |
0.16 |
| |
Sex (female) |
0.58 |
0.40–0.85 |
0.00 |
| Smoking status (former) | 0.78 | 0.54–1.12 | 0.18 |
Definition of abbreviations: CI = confidence interval; NLST = National Lung Screening Trial; OR = odds ratio; SEER = Surveillance, Epidemiology, and End Results.
Reference groups: group: SEER-Medicare; stage: 1A; Charlson Index: 0; sex: male; smoking status: current.